ESCGX
Price
$13.30
Change
+$0.09 (+0.68%)
Updated
Dec 26 closing price
Net Assets
16.34M
RNWAX
Price
$88.95
Change
+$0.20 (+0.23%)
Updated
Dec 26 closing price
Net Assets
75.3B
Interact to see
Advertisement

ESCGX vs RNWAX

Header iconESCGX vs RNWAX Comparison
Open Charts ESCGX vs RNWAXBanner chart's image
Ashmore Emerging Markets Equity ESG C
Price$13.30
Change+$0.09 (+0.68%)
VolumeN/A
Net Assets16.34M
American Funds New World R1
Price$88.95
Change+$0.20 (+0.23%)
VolumeN/A
Net Assets75.3B
ESCGX vs RNWAX Comparison Chart in %
View a ticker or compare two or three
VS
ESCGX vs. RNWAX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESCGX is a StrongBuy and RNWAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWAX has more cash in the bank: 75.3B vs. ESCGX (16.3M). ESCGX pays higher dividends than RNWAX: ESCGX (0.09) vs RNWAX (0.00). ESCGX was incepted earlier than RNWAX: ESCGX (6 years) vs RNWAX (24 years). ESCGX (3.14) is less costly to investors than RNWAX (1.66). ESCGX is a more actively managed with annual turnover of: 65.00 vs. RNWAX (37.00). RNWAX has a lower initial minimum investment than ESCGX: RNWAX (250) vs ESCGX (1000). ESCGX annual gain was more profitable for investors over the last year : 26.67 vs. RNWAX (18.60). RNWAX return over 5 years is better than : 7.55 vs. ESCGX (-4.62).
ESCGXRNWAXESCGX / RNWAX
Total Expense Ratio2.051.66123%
Annual Report Gross Expense Ratio3.141.66189%
Fund Existence6 years24 years-
Gain YTD29.65120.535144%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets16.3M75.3B0%
Annual Yield % from dividends0.090.00-
Returns for 1 year26.6718.60143%
Returns for 3 years53.5140.76131%
Returns for 5 years-4.627.55-61%
Returns for 10 yearsN/A83.04-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEUP3.790.02
+0.53%
Neuphoria Therapeutics Inc
APD245.841.07
+0.44%
Air Products & Chemicals
UAN96.790.14
+0.14%
CVR Partners LP
ALKS28.520.03
+0.11%
Alkermes plc
SMTI24.520.01
+0.04%
Sanara MedTech